THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial

Disclosure: S. Maraka: None. R. Owen: None. N.M. Singh Ospina: None. M. Knox: None. T. Dodds: None. H. Spencer: None. A. Albashaireh: None. A. Shah: None. S. Syed: None. S. Naqvi: None. H. Motahari: None. S. Thumma: None. E. Ambrogini: None. J.P. Brito: None. Objective: Levothyroxine (LT4) therapy h...

Descripción completa

Detalles Bibliográficos
Autores principales: Maraka, Spyridoula, Owen, Richard, Ospina, Naykky Maruquel Singh, Knox, Micheal, Dodds, Terri, Spencer, Horace, Dishongh, Katherine, Albashaireh, Arwa, Shah, Aashka, Syed, Sabah, Naqvi, Syeda, Motahari, Hooman, Thumma, Soumya, Ambrogini, Elena, Pablo Brito, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555089/
http://dx.doi.org/10.1210/jendso/bvad114.1787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555089/
http://dx.doi.org/10.1210/jendso/bvad114.1787

Ejemplares similares